Trial reportBMC psychiatry2025
An empirical study of offline and online group metacognitive training in patients with schizophrenia.
Trial report in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSchizophrenia often has hallucinations, delusions and other complex mental symptoms, metacognitive training (MCT) is a type of low-intensity group training. However, MCT requires a lot of time and expense, increasing the workload of professionals and the financial burden of patients. hybrid offline-online MCT reduces time and economic costs to the greatest extent. This study was designed to validate the interventional effects of a hybrid offline-online MCT model on psychiatric symptoms, delusion severity, and insight in patients with schizophrenia, while concurrently evaluating its clinical applicability.
methodsRandomized controlled trials comparing hybrid offline-online MCT were conducted in patients with paranoid schizophrenia. The positive and negative syndrome scale (PANSS), the Chinese version of the delusion feature rating scale (C-CDRS), the Chinese version of the psychotic symptom rating scale (PSYRATS), and the insight and treatment attitude questionnaire (ITAQ) were used to evaluate psychiatric symptom improvement and insight in the baseline (T0), 4 weeks after the initiation of training (T1), and upon completion of the training (T2, week 8).
resultsThe total scores of PANSS, C-CDRS, PSYRATS, and their subscale scores in the MCT and control groups were lower than baseline scores at weeks four and eight, while the total ITAQ score was higher than baseline scores (P < 0.01). In the MCT group, PANSS positive subscale and total score, C-CDRS total score, and PSYRATS delusion subscale and total score were lower than those in the control group at weeks four and eight, whereas the ITAQ total score was higher than the baseline score (P < 0.01).
conclusionsHybrid offline-online group MCT can reduce positive symptoms in patients with schizophrenia, alleviate delusions, and improve patients' insight.
trial registrationThe trial was registered at the Chinese Clinical Trial Registry on 01/24/2015 ( www.chictr.org.cn ; ChiCTRID: ChiCTR2500096505).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.